Table 1. Patient characteristics.

Summary of patient profiles for all subjects enrolled in this study. Included are demographic information, delivery route of fecal microbiota transplantation (FMT), underlying inflammatory bowel disease (IBD), and recorded number of prior Clostridium difficile infections (CDI) episodes.

ID	Sex	Race	FMT delivery method	Age (years) at FMT	Time FMT and post-FMT stool collection (Months)	Number of antibiotic courses prior to FMTc	Underlying IBD	Number of CDI episodes prior to FMT	FMT donor ID
1	F	Biracial	Colonoscopy	2	3	4	No	4	05
2	F	Black	Colonoscopy	7	9	1	Ulcerative Colitis	3	05
3	M	White	Colonoscopy	16	4	4	Ulcerative Colitis	4	05
4	F	Biracial	Colonoscopy	8	14	3	No	3	05
5	M	Black	Colonoscopy	10	7	4	Ulcerative Colitis	3	05
6	F	Black	Nasojejunal Tube	8	LTFUa	8	Ulcerative Colitis	3	05
7	M	White	Colonoscopy	1	6	4	No	4	37
8	F	White	Colonoscopy	7	4	2	Crohn’s Disease	3	37
9	F	White	Colonoscopy	18	4	2	No	2	37
10	F	White	Colonoscopy	2	6	2	No	3	37
11	F	White	Colonoscopy	8	6	2	No	5	37
12	M	White	Colonoscopy	2	LTFU	2	No	2	12
13	M	Biracialb	Colonoscopy	5	3	3	No	3	77
14	F	White	Colonoscopy	15	LTFU	7	No	3	66
15	M	White	Colonoscopy	10	2	1	No	3	77

Notes.

^aLTFU = Sample Lost to Follow Up.

^bBiracial = Participant self-identified as Black/White.

^cNumber of antibiotic courses only within the period of 12 months prior to FMT was included.

All patients had up to date vaccinations for routine immunizations, including Diphtheria-Tetanus-acellular Pertussis, Haemophilus influenzae Type B, Influenza, Pneumococcal Conjugate Vaccine, with seven or 13 Serogroups, Inactivated Polio Virus, Hepatitis A and B; Rotavirus; and Varicella.